8-K: Chemours Reports Mixed Q4, FY25 Results; Opteon Shines

Chemours reports mixed Q4 and full year 2025 results, with strong Opteon Refrigerants growth in TSS offsetting headwinds in other segments, while providing a positive 2026 outlook.

Summary

• Net Sales for Q4 2025 were $1.3 billion, a 2% decrease compared to the prior-year quarter, and flat at $5.8 billion for the full year 2025.
• A Net Loss attributable to Chemours of $47 million, or $0.31 per diluted share, was reported for Q4 2025, compared to a Net Loss of $11 million, or $0.08 per diluted share, in Q4 2024.
• The full year 2025 saw a Net Loss attributable to Chemours of $386 million, or $2.57 per diluted share, a significant decline from Net Income of $69 million, or $0.46 per diluted share, in 2024.
• Adjusted EBITDA for Q4 2025 was $128 million, down 24% year-over-year, and $742 million for the full year 2025, a 3% decrease from 2024.
• The Thermal & Specialized Solutions (TSS) segment achieved record fourth quarter and full year sales, with Opteon Refrigerants growing 37% year-over-year in Q4 and 56% for the full year.
• A global TiO2 price increase became effective on December 1, 2025.
• The sale of the former Kuan Yin TiO2 site was announced on January 15, 2026, expected to generate approximately $300 million in net proceeds.
• Free Cash Flows for Q4 2025 were $92 million, reflecting a Free Cash Flow Conversion of 72%.
• Consolidated gross debt stood at $4.2 billion as of December 31, 2025, with a net leverage ratio of approximately 4.7x on a trailing twelve-month Adjusted EBITDA basis.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed report with significant challenges in core segments leading to a substantial net loss, partially offset by strong performance in Opteon Refrigerants and a positive outlook for 2026, contingent on market recovery and strategic execution.

Positives

• Thermal & Specialized Solutions (TSS) segment reported record fourth quarter and full year sales, demonstrating strong performance.
• Opteon Refrigerants sales within TSS grew significantly by 37% year-over-year in Q4 2025 and 56% for the full year 2025, driven by the U.S. AIM Act stationary AC transition.
• A global TiO2 price increase was implemented effective December 1, 2025, which is expected to provide a strong foundation for 2026.
• The announced sale of the former Kuan Yin TiO2 site for approximately $300 million in net proceeds will provide significant cash inflow in 2026.
• Strong Free Cash Flows of $92 million in Q4 2025, with a 72% conversion rate, indicate effective cash generation.
• Corporate Expenses decreased by approximately $36 million in Q4 2025 due to lower litigation costs and ongoing cost reduction efforts under the 'Pathway to Thrive' strategy.
• The full year 2026 outlook projects consolidated Net Sales growth in the range of 3% to 5% and Adjusted EBITDA between $800 million and $900 million, indicating anticipated recovery and growth.

Negatives

• Net Sales were slightly down by 2% in Q4 2025 year-over-year and flat for the full year 2025, indicating limited top-line growth.
• A significant Net Loss attributable to Chemours of $47 million was reported in Q4 2025, and $386 million for the full year 2025, a substantial deterioration from prior periods.
• Adjusted EBITDA decreased by 24% in Q4 2025 and 3% for the full year 2025, with Q4 Adjusted EBITDA slightly below the expected range due to APM's performance.
• Titanium Technologies (TT) segment Net Sales decreased 11% in Q4 2025 and 6% for the full year, with Adjusted EBITDA down 67% in Q4 and 52% for the full year, primarily due to weaker demand and lower pricing in non-western markets.
• Advanced Performance Materials (APM) segment Net Sales decreased 4% in Q4 2025 and 5% for the full year, with Adjusted EBITDA down 74% in Q4 and 32% for the full year, impacted by cyclical end market weakness, a non-cash inventory charge of approximately $17 million, and unfavorable product mix.
• The net leverage ratio of approximately 4.7x as of December 31, 2025, is higher than the long-term objective of below three times Adjusted EBITDA.
• The Q1 2026 outlook for TT anticipates a sequential Net Sales decrease and Adjusted EBITDA between break-even and $5 million due to sales timing, mining changes, and higher cost impacts.
• The Q1 2026 outlook for APM projects a sequential Net Sales decrease in the high-teens percentage range and Adjusted EBITDA between break-even and $5 million, primarily due to an outage at the Washington Works facility with an estimated $20 million to $25 million earnings impact.

Risks

• Short-term cyclical end market headwinds are impacting the Advanced Performance Materials (APM) business.
• Weaker cyclically-sensitive end markets are affecting both Titanium Technologies (TT) and APM segments.
• Lower cost absorption tied to decreased production levels across APM and TT is impacting profitability.
• The company incurred a non-cash inventory charge and experienced an unfavorable product mix in APM.
• Higher input costs associated with R32, a key component of stationary Opteon Refrigerant blends, are affecting TSS margins.
• The overall TiO2 market remains challenged, particularly in non-western markets.
• Seasonality in western markets and destocking activity by North American customers are impacting TT volumes.
• Weakness in key end markets, customer timing, and constraints from an outage at the Washington Works facility are impacting APM's performance.
• Litigation-related charges and environmental liabilities, including those related to PFAS, continue to be a financial burden.
• General macroeconomic conditions remain tepid, posing a risk to overall demand.
• Forward-looking statements are subject to risks and uncertainties, including regulatory inquiries, changes in environmental regulations, tariffs, supply chain disruptions, and global health or weather events.

Future Outlook

For the full year 2026, Chemours anticipates consolidated Net Sales growth in the range of 3% to 5% and Adjusted EBITDA between $800 million and $900 million, primarily driven by increased TSS and APM Performance Solutions demand, expected pricing strength in TT, and continued cost improvement. Capital expenditures are projected to range from $275 million to $325 million, with Free Cash Flow Conversion expected to be above 25%. For the first quarter of 2026, consolidated Net Sales are expected to increase 3% to 5% sequentially, with Adjusted EBITDA between $120 million and $150 million. Q1 2026 Free Cash Flows are expected to reflect a use of cash not to exceed $100 million.

Management Comments

• Denise Dignam, Chemours President and CEO, stated, "Our consolidated fourth quarter results delivered robust cash flow and achieved revenue performance that met our expectations, highlighted by the continued transition to Opteon Refrigerants concluding a record setting year for TSS."
• Dignam also noted, "However, as a result of short-term cyclical end market headwinds experienced in our APM business, we elected to prioritize cash flow, leading to strong cash generation in the quarter. In connection with this approach APM incurred a sizable non-cash inventory charge and unfavorable product mix driving our consolidated Adjusted EBITDA slightly below our expected range."
• Regarding future strategy, Dignam commented, "Although macroeconomic conditions remain tepid, our pricing actions have begun to take effect in TiO2, and we remain focused on executing our broader Pathway to Thrive strategy."
• Dignam further added, "The sale of our Kuan Yin TiO2 site, along with increased organic cash flow generation in 2026, will provide significant cash inflow in 2026. These actions align with our capital allocation priorities under Pathway to Thrive, specifically improving our debt profile and progressing Chemours closer to our long-term objective of net leverage below three times adjusted EBITDA across economic cycles."

Industry Context

StockSavvy.ai notes that the strong performance of Opteon Refrigerants aligns with broader industry trends towards environmentally friendlier refrigerants, driven by regulations like the U.S. AIM Act. The challenges in Titanium Technologies and Advanced Performance Materials reflect ongoing cyclical weaknesses in industrial and construction end markets, which have impacted several chemical producers globally. The strategic focus on cash flow generation and debt reduction is a common response among companies facing macroeconomic uncertainties.

Comparison to Industry Standards

• The 37% YoY growth in Opteon Refrigerants in Q4 2025 and 56% YoY for FY 2025 significantly outperforms typical growth rates in mature chemical segments, indicating strong market penetration and regulatory tailwinds for next-generation refrigerants.
• The decline in Titanium Technologies' Adjusted EBITDA by 67% in Q4 2025 and 52% for FY 2025 is steeper than some peers who have managed to stabilize margins through cost control, though the TiO2 market has been broadly challenged. For example, Venator Materials (VNTR) and Kronos Worldwide (KRO) have also reported significant pressures in their TiO2 segments due to oversupply and weak demand.
• The net leverage ratio of 4.7x is higher than the industry average for specialty chemical companies, which typically aim for 2-3x, indicating a more leveraged position compared to companies like PPG Industries (PPG) or Sherwin-Williams (SHW) which often maintain lower leverage.
• The projected 3-5% Net Sales growth for FY 2026 is in line with moderate recovery expectations for the broader chemical industry, assuming a stabilization of macroeconomic conditions.

Legal Proceedings

• The full year 2025 Net Loss was primarily driven by litigation-related charges, including the announced settlement with the State of New Jersey.
• Litigation-related charges for FY 2025 include $270 million related to the company's portion of the Chemours, DuPont, Corteva, EID, and State of New Jersey's settlement agreement reached in August 2025.
• $12 million in third-party legal fees directly related to the New Jersey Settlement agreement were incurred.
• $14 million related to the company's portion of Chemours, DuPont, Corteva, EID's settlement agreement to resolve the Hoosick Falls class action lawsuit.
• $18 million related to reserves for asbestos and production liability matters.
• Environmental charges for FY 2025 primarily include changes in remediation reserves at the four sites covered by the New Jersey settlement agreement.
• Restricted cash approximated $54 million at the end of Q4 2025, reflecting primarily escrow payments related to the MOU agreement with DuPont, Corteva and EID.

Related Party Transactions

• Qualified spend recovery represents costs and expenses reimbursable by DuPont and/or Corteva as part of a cost-sharing agreement under the terms of the MOU.
• Restricted cash includes escrow payments related to the MOU agreement with DuPont, Corteva and EID.

Stakeholder Impact

• **Shareholders:** Experienced a significant net loss for FY 2025, but the positive outlook for 2026, strong Q4 cash flow, and asset sale may offer some reassurance. Debt reduction efforts are positive for long-term value.
• **Employees:** Operational adjustments and cost reduction efforts under 'Pathway to Thrive' could imply workforce optimization, though not explicitly detailed.
• **Customers:** Benefit from continued strong supply of Opteon Refrigerants, but challenges in TT and APM segments may indicate fluctuating product availability or pricing.
• **Creditors:** The high net leverage ratio (4.7x) is a concern, but the sale of the Kuan Yin site and focus on cash generation and debt reduction are positive signals for debt servicing capacity.

Next Steps

• A conference call and webcast will be held on February 20, 2026, at 8:00 AM Eastern Time to discuss the results.
• The company plans to continue executing its 'Pathway to Thrive' strategy, focusing on improving its debt profile and achieving a net leverage ratio below three times Adjusted EBITDA.
• Realization of expected pricing strength in TT and continued cost improvement in TT and APM are anticipated throughout 2026.
• The Annual Report on Form 10-K for the year ended December 31, 2025, will provide further details on certain prior period revisions, restricted cash, and litigation/environmental matters.

Key Dates

Recommendation

While Chemours reported a substantial net loss for the full year 2025 and faced headwinds in its TT and APM segments, the strong performance of Opteon Refrigerants in TSS, robust Q4 cash flow, and a positive 2026 outlook provide a basis for holding. The announced sale of the Kuan Yin TiO2 site and the commitment to debt reduction are strategic positives. However, the high net leverage ratio and ongoing cyclical weaknesses in key markets warrant caution, preventing a 'buy' recommendation until a clearer path to sustained profitability and deleveraging is demonstrated.

Keywords

Chemours, CC, Q4 2025, Full Year 2025, Financial Results, Earnings, Opteon Refrigerants, Titanium Dioxide, TiO2, Advanced Performance Materials, Thermal & Specialized Solutions, SEC Filing, 8-K, Financial Performance, Adjusted EBITDA, Net Sales, Net Loss, Free Cash Flow, Chemical Industry, PFAS